Changes in monoamine metabolites concentrations in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, trazodone

Pharmacological Research

Volumn 40, Issue 6, 1999, Pages 503-508

  Egashira, T ^a   Takayama, F ^a   Yamanaka, Y ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Antidepressant; Cerebrospinal fluid; Monoamine metabolite; Selective serotonin reuptake inhibitors; Trazodone

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; MONOAMINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; LIGHT DARK CYCLE; LONG TERM CARE; MALE; METABOLITE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

EID: 0032763098     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0546     Document Type: Article

References (15)

1. Ban T A, Lehmann H E, Amin M, Bromheim L A, Kilinger A, Nair N PV, Galvan L, Vergara L, Zoch C. Differential effects of trazodone in depressed, schizophrenic and geriatric patients. Int J Clin Pharmacol. 9:1974;23-27.
2. Stefanini E, Fadda F, Medda L, Gessa G L. Selective inhibition of serot onin uptake by trazodone, a new antidepressant agent. Life Sci. 18:1976;1459-1466.
3. Bara L, Maj J, Rogoz Z, Skuza G. On central antiserotonin action of Tr azodone. Pol J Pharmacol Pharm. 31:1979;25-33.
4. Caccia S, Ballabio M, Samanin R, Zanini M G, Garattini S. (-)- m -Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of Trazodone. J Pharm Pharmacol. 33:1981;477-478.
5. Matsumoto M, Togashi H, Yoshioka M, Morii K, Hirokami M, Tochihara M, Ikeda T, Saito Y, Saito H. Significant correlation between cerebrospinal fluid and brain levels of norepinephrine, serotonin and acetylcholine in anesthetized rats. Life Sci. 48:1991;823-829.
6. Wada Y, Egashira T, Takayama F, Yamanaka Y, Takada K, Takeda H, Matsumiya T. Variation of monoamines and their metabolite concentrations in the cerebrospinal fluid of conscious rats. Jpn J Pharmacol. 78:1998;237-240.
7. Takemoto Y. An improved method for using cisternal cerebrospinal fluid in conscious rats for application in the measurement of catecholamines. Jpn J Physiol. 41:1991;665-669.
8. Ikegami A, Maeda A, Hara H, Yamashita A, Sukamoto T, Ito K. Effect of trazodone (KB-831) and its metabolites on brain monoamines in rat. Folia Pharmacol Jpn. 93:1989.
9. Takeda H, Matsumiya T, Shibuya T. Detection and identification modes for the highly sensitive and simultaneous determination of various biogenic amines by courometric high performance liquid chromatography. J Chromatogr. 515:1990;265-278.
10. Koyama T, Abe M, Kusumi I, Odagaki Y, Yamashita I. Effect of acute treatment with trazodone on monoamine dynamics in the rat brain by in vivo microdialysis. Jpn J Psychopharmacol. 12:1992.
11. Wauquier A, Dugovic C. Serotonin and sleep- wakefulness. Ann NY Acad Sci. 600:1990;447-459.
12. Portas C M, Bjorvatn B, Fagerland S, Gronli J, Mundal V, Sorensen E, Ursin R. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience. 83:1998;807-814.
13. Ursin R, Bjorvatn B, Sommerfelt L, Underland G. Increased waking as well as increased synchronisation following administration of selective 5-HT uptake inhibitors to rats. Behav Brain Res. 34:1989;117-130.
14. Sommerfelt L, Ursin R. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimelidine and alaproclate in cats. Behav Brain Res. 45:1991;105-115.
15. Lelkes Z, Obal F Jr Z, Alfoldi P, Erdos A, Rubicsek G, Benedek G. Effects of acute and chronic treatment with Trazodone, an antidepressant, on the sleep-wake activity in rats. Pharmacol Res. 30:1994;105-115.